Valuation of the safety of recombinant adenovirus coding human IL-12 protein on mice

To evaluate the safety of recombinant adenovirus coding the human IL-12 protein in mice. Subjects and methods: BALB/c mice were divided into 3 groups, each group of 9 mice, including control group, recombinant adenovirus coding the human IL-12 protein injection group at 106 vp/head, recombinant adenovirus coding the human IL-12 protein injection group at 107 vp/head.